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Summary Thrombotic thrombocytopenic purpura (TTP) is an ischemic vasculopa-
thy frequently associated with neurological dysfunction including seizures. However,
status epilepticus (SE) has rarely been reported in this condition. We report on a
70-year-old woman with fulminant TTP who developed convulsive SE despite high
therapeutic serum levels of phenytoin and phenobarbital. Her electroencephalogram
(EEG) was characterized by bilateral independent periodic lateralizing epileptiform
discharges (BIPLEDs) propagating into clinical and electrographic seizures. She re-
covered completely after intensive plasmapheresis and treatment with pentobarbital
induced coma for 5 days. This case illustrates that aggressive treatment with pento-
barbital and plasmapheresis may prevent permanent neurologic deﬁcits when TTP is
complicated by SE and that periodic lateralizing epileptiform discharges (PLEDs) in
this syndrome can be the manifestation of a reversible ischemic insult.
© 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
Introduction
Thrombotic thrombocytopenic purpura (TTP) is a
rare syndrome of unknown etiology characterized
by thrombocytopenia, microangiopathic hemolytic
anemia, neurological abnormalities, renal impair-
ment and fever. In its fulminant form, diffuse
thrombotic lesions in the central nervous system
cause seizures and coma.1 Its prognosis was once
considered uniformly poor, with a high mortality
rate.2,3 Since the introduction of plasma infusions
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and exchanges, the prognosis of the disease has
improved dramatically; remissions now occur in
80—90% of patients.3
Neurologic symptoms and signs are amongst
the most common presentation of TTP, includ-
ing alteration in the level of awareness, waxing
and waning neurological deﬁcits, headaches and
coma.4 Although seizures have been described
in patients with TTP,5—7 status epilepticus (SE) is
rarely reported.8,9
We describe an elderly woman with TTP who
developed convulsive SE during her illness associ-
ated with bilateral independent periodic lateraliz-
ing epileptiform discharges (BIPLEDs) on EEG. She
completely recovered and the electroencephalo-
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gram (EEG) normalized following treatment with
pentobarbital-induced coma and intensive plasma-
pheresis.
Case report
A 70-year-old woman with a history of diverticuli-
tis and peptic ulcer was admitted to a community
hospital because of abdominal pain and bloody diar-
rhea. Her platelet count was 53,000mm−3 and cre-
atinine level was 210mol/l. One week earlier, her
platelet count was 290,000mm−3. Brain computed
tomography (CT) and cerebrospinal ﬂuid examina-
tion were normal. Two days after admission, she
was transferred to the University of Michigan Med-
ical Center because of progressive confusion and
focal motor seizures. On admission, her temper-
ature was 100.2 ◦F, blood pressure 120/72mmHg,
and pulse rate 82min−1. She was lethargic, disori-
ented to time, and complained of abdominal and
back pain. She was unable to look past midline on
attempted left lateral gaze and her left plantar
response was equivocal. Physical examination was
otherwise unremarkable.
Laboratory results revealed hemoglobin 10.8 g/dl,
hematocrit 27.7%, white blood cell count 9100mm−3,
platelet count 27,000mm−3, creatinine 270mol/l,
LDH 1326 IU/l (normal 60—200), ﬁbrinogen 2.7 g/l
(normal 1.5—3.5), erythrocyte sedimentation rate
15mm/h (normal 0—20), prothrombin time 13.4 s,
partial thromboplastin time 22 s and reticulocyte
count 2.9% (normal 0.5—1.5). A peripheral blood
smear revealed moderate numbers of schistocytes
and few helmet cells. Bone marrow aspiration and
biopsy showed an increased number of megakary-
ocytes.
Treatment for TTP began immediately with
plasma infusions. The following day, her mental
status was normal, but during the next few days,
Figure 1 EEG during SE showing markedly disorganized background, BIPLEDs and onset of a focal seizure in the right
hemisphere.
despite a decrease in serum creatinine levels,
she was intermittently confused. Three days after
admission, the patient experienced a single gen-
eralized tonic-clonic (GTC) seizure for which she
received an intravenous loading dose of phenytoin.
Repeat brain CT was normal except for a small low
density lesion in the hypothalamus. She was started
on daily plasmapheresis for 3 days. Six days after
admission, she was found stuporous, responding
to painful stimuli only with eye opening, moaning
and withdrawal of the extremities. Both plantar
responses were extensor. Another brain CT did not
show any changes compared to the previous scan.
Lumbar puncture yielded clear, colorless ﬂuid with
a protein level of 0.85 g/l (normal 0.15—0.4), nor-
mal glucose, seven red blood cells and two white
blood cells per high power ﬁeld. A few hours later,
the patient had serial GTC seizures and received an
intravenous loading dose of phenobarbital. Despite
a serum phenytoin level of 100mol/l and phe-
nobarbital level of 150mol/l, she developed SE.
Over 8 h she had approximately 40 seizures, each
beginning with clonic activity of the left arm that
secondarily generalized. EEG revealed BIPLEDs and
in a 25min recording, ﬁve clinical and two elec-
trographic (subclinical) seizures occurred (Fig. 1).
Laboratory studies revealed a platelet count of
190,000mm−3, creatinine 270mol/l, and ﬁbrino-
gen of 2.6 g/l. Blood, sputum and urine cultures
were negative.
Treatment with intravenous pentobarbital infu-
sion was initiated to induce a burst suppression
pattern on EEG, after which her seizures ceased.
Plasmapheresis was resumed daily for 3 days fol-
lowed by three more sessions every other day.
The pentobarbital infusion was gradually tapered
and discontinued after 5 days and the EEG was
monitored to ensure no return of electrographic
seizures. The next day she opened her eyes to loud
voices but did not follow commands. EEG revealed
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diffuse slowing without epileptiform activity. Over
the next several days her mental status gradually
improved, blood counts and clotting studies re-
turned to normal, and she was discharged from
the hospital without neurological deﬁcits. A subse-
quent EEG was normal. At last follow-up, 3 years
after the illness, she remained seizure free with a
normal neurological examination.
Discussion
Our patient demonstrated the diagnostic pentad
for TTP, including the presence of thrombocytope-
nia, microangiopathic hemolytic anemia, neurolog-
ical abnormalities, renal impairment and fever. This
syndrome usually occurs in younger individuals. The
median onset is 35 years; only 6% of the patients
are older than 60 years.5 While only 50% of pa-
tients have neurological manifestation at presenta-
tion, 90% developed them during the course of the
illness.1,4,6 In a review of 529 patients with TTP,
the most common neurological manifestations were
alteration of mental status (35%), headache (32%),
coma (24%), focal weakness (24%), aphasia (19%),
seizures (15%), and visual changes (10%).4
These and other clinical features are believed to
be due to widespread vascular occlusions caused
by characteristic hyaline thrombi in terminal ar-
terioles and capillaries.3,4 The most frequently
involved organs are the heart, brain, kidneys, pan-
creas and adrenals.10 Neuropathological changes
include small vessel occlusion in the cortical and
subcortical grey matter, some of which are associ-
ated with small infarctions.6
Although, seizures have been reported in 12—41%
of patients with TTP,2,5—7 SE is rarely diagnosed.8,9
In one study, two patients with TTP and al-
tered mental status were diagnosed to be in
non-convulsive SE.9 One patient died and the other
recovered with mild neurologic deﬁcit follow-
ing treatment with pentobarbital induced coma.9
There is another published report of an elderly
woman with TTP and intermittent stupor, who was
found to be in non-convulsive SE.8 The status was
aborted following treatment with anticonvulsants.
The patient subsequently expired because of respi-
ratory failure.8 Seizures are probably secondary to
widespread ischemia of the cerebral cortex and are
most commonly generalized.2 Although our patient
was in convulsive SE, two of her seizures were sub-
clinical. This stresses the importance of a high level
of suspicion for the possibility of SE in patients with
TTP, especially in those with alteration in level of
awareness or those in coma.9 To our knowledge,
no case with EEG ﬁndings of PLEDs or BIPLEDs as-
sociated with TTP has been reported in the liter-
ature. PLEDs are usually associated with seizures
and carry an increased risk of mortality.11,12 Al-
though they usually occur in the setting of a acute
structural lesions, cases due to toxic or metabolic
abnormalities have also been reported.11,13 The BI-
PLEDs seen in our patient’s EEG suggested an acute
and multifocal ischemic insult. The subsequent dis-
appearance of those discharges and the return of
normal background activity, coinciding with clinical
improvement, indicate that the ischemic insult in
this patient was largely reversible and that PLEDs
in this syndrome are not necessarily indicative of a
permanent structural lesion.
Despite her advanced age, our patient responded
to treatment with plasmapheresis and pentobarbi-
tal induced coma. In the past, recurrent seizures
and progression into coma constituted a frequent
terminal event.2 Improved survival has been at-
tributed to treatment with plasma infusions and
plasmapheresis. Current recommendations for
treatment also include antiplatelet agents, corti-
costeroids, and in resistant cases, splenectomy and
vincristine.3,14
This case illustrates that complete neurological
recovery is possible even when fulminant TTP is
complicated by convulsive SE. It also suggests that
the presence of PLEDs in this syndrome is not nec-
essarily indicative of a permanent structural lesion.
The transient nature of this EEG ﬁnding is fully con-
sistent with a reversible ischemic insult.
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